Only the DNA Binding and Transactivation Domains of c-Myb Are Required to Block Terminal Differentiation of Murine Erythroleukemia Cells

REFERENCES

• Bading, H., C. Beutler, and K. Moelling. 1989. Mapping of a small phosphopeptide at the carboxy terminus of the viral myb protein by monoclonal antibodies. Oncogene 4:33–38.
   PubMedGoogle Scholar
• Bar-Ner, M., L. T. Messing, C. M. Cultraro, M. J. Birrer, and S. Segal. 1992. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. Cell Growth Differ. 3:183–190.
   PubMedGoogle Scholar
• Bender, T. P., and W. M. Kuehl. 1986. Murine myb protooncogene mRNA: cDNA sequence and evidence for 5′ heterogeneity. Proc. Natl. Acad. Sci. USA 83:3204–3208.
   PubMed Web of Science ®Google Scholar
• Bender, T. P., and W. M. Kuehl. 1987. Differential expression of the c-myb proto-oncogene marks the pre-B cell/B cell junction in murine B lymphoid tumors. J. Immunol. 139:3822–3827.
   PubMedGoogle Scholar
• Biedenkapp, H., U. Borgmeyer, A. E. Sippel, and K.-H. Klempnauer. 1988. Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature (London) 335:835–837.
   PubMed Web of Science ®Google Scholar
• Clarke, M. F., L. J. Kukowska, E. Westin, M. Smith, and E. V. Prochownik. 1988. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol. Cell. Biol. 8:884–892.
   PubMed Web of Science ®Google Scholar
• Cogswell, J. P., P. C. Cogswell, W. M. Kuehl, A. M. Cuddihy, T. M. Bender, U. Engelke, K. B. Marcu, and J. P.-Y. Ting. 1993. Mechanism of c-myc regulation by c-Myb in different cell lineages. Mol. Cell. Biol. 13:2858–2869.
   PubMed Web of Science ®Google Scholar
• Cogswell, J. T. 1993. Personal communication.
   Google Scholar
• Danish, R., O. el Awar, B. L. Weber, J. Langmore, L. A. Turka, J. J. Ryan, and M. F. Clarke. 1992. c-myb effects on kinetic events during MEL cell differentiation. Oncogene 7:901–907.
   PubMedGoogle Scholar
• Davis, L. G., M. D. Dibner, and J. F. Battey. 1986. Basic methods in molecular biology. Elsevier Science Publishing Co., New York.
   Google Scholar
• Evans, J. L., T. L. Moore, W. M. Kuehl, T. Bender, and J. P.-Y. Ting. 1990. Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it trans-activates the c-myc promoter. Mol. Cell. Biol. 10:5747–5752.
   PubMedGoogle Scholar
• Gabrielsen, O. S., A. Sentenac, and P. Fromageot. 1991. Specific DNA binding by c-Myb: evidence for a double helix-turn-helix-related motif. Science 253:1140–1143.
   PubMed Web of Science ®Google Scholar
• Gewirtz, A. M., and B. Calabretta. 1988. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 242:1303–1306.
   PubMed Web of Science ®Google Scholar
• Gonda, T. J., C. Buckmaster, and R. G. Ramsay. 1989. Activation of c-myb by carboxy-terminal truncation: relationship to transformation of murine haemopoietic cells in vitro. EMBO J. 8:1777–1783.
   PubMed Web of Science ®Google Scholar
• Gonda, T. J., and D. Metcalf. 1984. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature (London) 310:249–251.
   PubMed Web of Science ®Google Scholar
• Grasser, F. A., T. Graf, and J. S. Lipsick. 1991. Protein truncation is required for the activation of the c-myb protooncogene. Mol. Cell. Biol. 11:3987–3996.
   PubMedGoogle Scholar
• Hoffman-Liebermann, L. B., and D. A. Liebermann. 1991. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells. Oncogene 6:903–909.
   PubMedGoogle Scholar
• Holt, J. T., T. V. Gopal, A. D. Moulton, and A. W. Nienhuis. 1986. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc. Natl. Acad. Sci. USA 83:4794–4798.
   PubMed Web of Science ®Google Scholar
• Howe, K. M., and R. J. Watson. 1991. Nucleotide preferences in sequence-specific recognition of DNA by c-myb. Nucleic Acids Res. 19:3913–3919.
   PubMed Web of Science ®Google Scholar
• Hu, Y. L., R. G. Ramsay, C. Kanei-Ishii, S. Ishii, and T. J. Gonda. 1991. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain. Oncogene 6:1549–1553.
   PubMedGoogle Scholar
• Ibanez, C. E., and J. S. Lipsick. 1988. Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation. J. Virol. 62:1981–1988.
   PubMedGoogle Scholar
• Ibanez, C. E·, and J. S. Lipsick. 1990. trans-activation of gene expression by v-myb. Mol. Cell. Biol. 10:2285–2293.
   PubMed Web of Science ®Google Scholar
• Johnson, G. D., and G. M. d. C. Nogueira Aruajo. 1981. A simple method of reducing the fading of immunofluorescence during microscopy. J. Immunol. Methods 43:340–350.
   Google Scholar
• Kahn, S., W. Jiang, C. Borner, K. O’Driscoll, and I. B. Weinstein. 1990. Construction of defined deletion mutants by thermal cycled fusion: applications to protein kinase C. Technique 2:27–30.
   Google Scholar
• Kalkbrenner, F., S. Guehmann, and K. Moelling. 1990. Transcriptional activation by human c-myb and v-myb genes. Oncogene 5:657–661.
   PubMedGoogle Scholar
• Kanei-Ishii, C., E. M. MacMillan, T. Nomura, A. Sarai, R. G. Ramsay, S. Aimoto, S. Ishii, T. J. Gonda. 1992. Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc. Natl. Acad. Sci. USA 89:3088–3092.
   PubMedGoogle Scholar
• Kirsch, I. R., V. Bertness, J. Silver, and G. F. Hollis. 1986. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation. J. Cell. Biochem. 32:11–21.
   PubMedGoogle Scholar
• Klempnauer, K. H., T. J. Gonda, and J. M. Bishop. 1982. Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell 31:453–463.
   PubMed Web of Science ®Google Scholar
• Kuehl, W. M. Unpublished data.
   Google Scholar
• Kuehl, W. M., T. P. Bender, J. Stafford, D. McClinton, S. Segal, and E. Dmitrovsky. 1988. Expression and function of the c-myb oncogene during hematopoietic differentiation. Curr. Top. Microbiol. Immunol. 141:318–323.
   PubMedGoogle Scholar
• Lane, T., C. Ibanez, A. Garcia, T. Graf, and J. Lipsick. 1990. Transformation by v-myb correlates with trans-activation of gene expression. Mol. Cell. Biol. 10:2591–2598.
   PubMedGoogle Scholar
• Luscher, B., E. Christenson, D. W. Litchfield, E. G. Krebs, and R. N. Eisenman. 1990. Myb DNA binding inhibited by phos-phorylation at a site deleted during oncogenic activation. Nature (London) 344:517–522.
   PubMedGoogle Scholar
• Luscher, B., and R. N. Eisenman. 1988. c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol. Cell. Biol. 8:2504–2512.
   PubMedGoogle Scholar
• Luscher, B., and R. N. Eisenman. 1990. New light on Myc and Myb. II. Myb. Genes Dev. 4:2235–2241.
   PubMed Web of Science ®Google Scholar
• McClinton, D., J. Stafford, L. Brents, T. P. Bender, and W. M. Kuehl. 1990. Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene. Mol. Cell. Biol. 10:705–710.
   PubMedGoogle Scholar
• Mucenski, M. L., K. McLain, A. B. Kier, S. H. Swerdlow, C. M. Schreiner, T. A. Miller, D. W. Pietryga, W. J. Scott, and S. S. Potter. 1991. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677–689.
   PubMed Web of Science ®Google Scholar
• Nakagoshi, H., C. Kanei-Ishii, T. Sawazaki, G. Mizuguchi, and S. Ishii. 1992. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7:1233–1240.
   PubMed Web of Science ®Google Scholar
• Nakagoshi, H., T. Nagase, Y. Ueno, and S. Ishii. 1989. Transcriptional trans-repression by the c-myb proto-oncogene product. Nucleic Acids Res. 17:7315–7324.
   PubMedGoogle Scholar
• Ness, S. A., A. Marknell, and T. Graf. 1989. The v-myb oncogene product binds to and activates the promyelocytespecific mim-1 gene. Cell 59:1115–1125.
   PubMed Web of Science ®Google Scholar
• Nicolaides, N. C·, R. Gualdi, C. Casadevall, L. Manzella, and B. Calabretta. 1991. Positive autoregulation of c-myb expression via Myb binding sites in the 5′ flanking region of the human c-myb gene. Mol. Cell. Biol. 11:6166–6176.
   PubMed Web of Science ®Google Scholar
• Peters, C. W. B., A. E. Sippel, M. Vingron, and K.-H. Klempnauer. 1987. Drosophila and vertebrate myb proteins share two conserved regions, one of which functions as a DNA-binding domain. EMBO J. 6:3085–3090.
   PubMedGoogle Scholar
• Ramsay, R. G., S. Ishii, and T. J. Gonda. 1991. Increase in specific DNA binding by carboxyl truncation suggests a mech-anism for activation of Myb. Oncogene 6:1875–1879.
   PubMedGoogle Scholar
• Ramsay, R. G., S. Ishii, Y. Nishina, G. Soe, and T. J. Gonda. 1989. Characterization of alternate and truncated forms of murine c-myb proteins. Oncogene Res. 4:259–269.
   PubMedGoogle Scholar
• Reuben, R. C., R. L. Wife, R. Breslow, R. A. Rifkind, and P. A. Marks. 1976. A new group of potent inducers of differentiation in murine erythroleukemia cells. Proc. Natl. Acad. Sci. USA 73:862–866.
   PubMed Web of Science ®Google Scholar
• Saikumar, P., R. Murali, and E. P. Reddy. 1990. Role of tryptophan repeats and flanking amino acids in Myb-DNA interactions. Proc. Natl. Acad. Sci. USA 87:8452–8456.
   PubMed Web of Science ®Google Scholar
• Sakura, H., C. Kanei-Ishii, T. Nagase, H. Nakagoshi, T. J. Gonda, and S. Ishii. 1989. Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc. Natl. Acad. Sci. USA 86:5758–5762.
   PubMed Web of Science ®Google Scholar
• Shen-Ong, G. L. C. 1990. The myb oncogene. Biochim. Biophys. Acta 1032:39–52.
   PubMedGoogle Scholar
• Siu, G., A. L. Wurster, J. S. Lipsick, and S. M. Hedrick. 1992. Expression of the CD4 gene requires a Myb transcription factor. Mol. Cell. Biol. 12:1592–1604.
   PubMedGoogle Scholar
• Spotts, G. D., and S. R. Hann. 1990. Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells. Mol. Cell. Biol. 10:3952–3964.
   PubMedGoogle Scholar
• Thiele, C. J., P. S. Cohen, and M. A. Israel. 1988. Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol. Cell. Biol. 8:1677–1683.
   PubMed Web of Science ®Google Scholar
• Todokoro, K., R. J. Watson, H. Higo, H. Amanuma, S. Kuramo- chi, H. Yanagisawa, and Y. Ikawa. 1988. Down-regulation of c-myb gene expression is a prerequisite for erythropoietin- induced erythroid differentiation. Proc. Natl. Acad. Sci. USA 85:8900–8904.
   PubMed Web of Science ®Google Scholar
• Weber, B. L., E. H. Westin, and M. F. Clarke. 1990. Differentiation of mouse erythroleukemia cells enhanced by alterna-tively spliced c-myb mRNA. Science 249:1291–1293.
   PubMedGoogle Scholar
• Westin, E. H., R. C. Gallo, S. K. Arya, A. Eva, L. M. Souza, M. A. Baluda, S. A. Aaronson, and F. Wong-Staal. 1982. Differential expression of the amv gene in human hematopoietic cells. Proc. Natl. Acad. Sci. USA 79:2194–2198.
   PubMed Web of Science ®Google Scholar
• Weston, K., and J. M. Bishop. 1989. Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell 58:85–93.
   PubMed Web of Science ®Google Scholar
• Zobel, A., F. Kalkbrenner, S. Guehmann, M. Nawrath, G. Vorbrueggen, and K. Moelling. 1991. Interaction of the v- and c-Myb proteins with regulatory sequences of the human c-myc gene. Oncogene 6:1397–1407.
   PubMedGoogle Scholar
• Zobel, A., F. Kalkbrenner, G. Vorbrueggen, and K. Moelling. 1992. Transactivation of the human c-myc gene by c-Myb. Biochem. Biophys. Res. Commun. 186:715–722.
   PubMedGoogle Scholar